These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 22069486

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12.
    Melo RCC, Longhini AL, Bigarella CL, Baratti MO, Traina F, Favaro P, de Melo Campos P, Saad ST.
    PLoS One; 2014; 9(1):e85926. PubMed ID: 24497931
    [Abstract] [Full Text] [Related]

  • 23. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
    Grymula K, Tarnowski M, Wysoczynski M, Drukala J, Barr FG, Ratajczak J, Kucia M, Ratajczak MZ.
    Int J Cancer; 2010 Dec 01; 127(11):2554-68. PubMed ID: 20162608
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
    Li X, Guo H, Duan H, Yang Y, Meng J, Liu J, Wang C, Xu H.
    Sci Rep; 2015 Nov 05; 5():16228. PubMed ID: 26538086
    [Abstract] [Full Text] [Related]

  • 26. AMD3100 and G-CSF disrupt the cross-talk between leukemia cells and the endosteal niche and enhance their sensitivity to chemotherapeutic drugs in biomimetic polystyrene scaffolds.
    Shen ZH, Zeng DF, Kong PY, Ma YY, Zhang X.
    Blood Cells Mol Dis; 2016 Jul 05; 59():16-24. PubMed ID: 27282562
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.
    Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM, Spencer JA, Kimlinger T, Ghobrial JM, Jia X, Lu G, Timm M, Kumar A, Côté D, Veilleux I, Hedin KE, Roodman GD, Witzig TE, Kung AL, Hideshima T, Anderson KC, Lin CP, Ghobrial IM.
    Blood; 2007 Apr 01; 109(7):2708-17. PubMed ID: 17119115
    [Abstract] [Full Text] [Related]

  • 28. Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling.
    Spiegel A, Kollet O, Peled A, Abel L, Nagler A, Bielorai B, Rechavi G, Vormoor J, Lapidot T.
    Blood; 2004 Apr 15; 103(8):2900-7. PubMed ID: 15070661
    [Abstract] [Full Text] [Related]

  • 29. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
    Hirbe AC, Morgan EA, Weilbaecher KN.
    Curr Pharm Des; 2010 Apr 15; 16(11):1284-90. PubMed ID: 20166978
    [Abstract] [Full Text] [Related]

  • 30. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
    Chen Z, Teo AE, McCarty N.
    Clin Cancer Res; 2016 Jan 01; 22(1):187-99. PubMed ID: 26350264
    [Abstract] [Full Text] [Related]

  • 31. Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist.
    Parameswaran R, Yu M, Lim M, Groffen J, Heisterkamp N.
    Leukemia; 2011 Aug 01; 25(8):1314-23. PubMed ID: 21483439
    [Abstract] [Full Text] [Related]

  • 32. [The expression and clinical significance of stromal cell-derived factor-1 and CXCR4 in acute leukemia and malignant lymphoma].
    Zeng DF, Kong PY, Chen XH, Wei L, Chang C, Peng XG.
    Zhonghua Nei Ke Za Zhi; 2005 Jul 01; 44(7):522-4. PubMed ID: 16080846
    [Abstract] [Full Text] [Related]

  • 33. Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells.
    Nakamura T, Shinriki S, Jono H, Guo J, Ueda M, Hayashi M, Yamashita S, Zijlstra A, Nakayama H, Hiraki A, Shinohara M, Ando Y.
    Oncotarget; 2015 Jan 20; 6(2):1008-19. PubMed ID: 25504440
    [Abstract] [Full Text] [Related]

  • 34. SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.
    Dillenburg-Pilla P, Patel V, Mikelis CM, Zárate-Bladés CR, Doçi CL, Amornphimoltham P, Wang Z, Martin D, Leelahavanichkul K, Dorsam RT, Masedunskas A, Weigert R, Molinolo AA, Gutkind JS.
    FASEB J; 2015 Mar 20; 29(3):1056-68. PubMed ID: 25466898
    [Abstract] [Full Text] [Related]

  • 35. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
    Juarez J, Dela Pena A, Baraz R, Hewson J, Khoo M, Cisterne A, Fricker S, Fujii N, Bradstock KF, Bendall LJ.
    Leukemia; 2007 Jun 20; 21(6):1249-57. PubMed ID: 17410186
    [Abstract] [Full Text] [Related]

  • 36. Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.
    Bradstock KF, Makrynikola V, Bianchi A, Shen W, Hewson J, Gottlieb DJ.
    Leukemia; 2000 May 20; 14(5):882-8. PubMed ID: 10803521
    [Abstract] [Full Text] [Related]

  • 37. Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma.
    Gentilini A, Rombouts K, Galastri S, Caligiuri A, Mingarelli E, Mello T, Marra F, Mantero S, Roncalli M, Invernizzi P, Pinzani M.
    J Hepatol; 2012 Oct 20; 57(4):813-20. PubMed ID: 22727731
    [Abstract] [Full Text] [Related]

  • 38. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
    Juarez J, Bradstock KF, Gottlieb DJ, Bendall LJ.
    Leukemia; 2003 Jul 20; 17(7):1294-300. PubMed ID: 12835717
    [Abstract] [Full Text] [Related]

  • 39. Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
    Welschinger R, Liedtke F, Basnett J, Dela Pena A, Juarez JG, Bradstock KF, Bendall LJ.
    Exp Hematol; 2013 Mar 20; 41(3):293-302.e1. PubMed ID: 23178377
    [Abstract] [Full Text] [Related]

  • 40. Role of CXCR4 in the progression and therapy of acute leukaemia.
    Su L, Hu Z, Yang YG.
    Cell Prolif; 2021 Jul 20; 54(7):e13076. PubMed ID: 34050566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.